Available downloads

All links are direct pdf downloads of ECHO session presentations unless specified.

Entries tagged with "buprenorphine"

PDF MATOD - A Tasmanian Perspective
Session date: March 23, 2022

PDF Prenatal exposure to methadone or buprenorphine
Session date: March 16, 2022
An overview of the long term effects or prenatal exposure to MATOD drugs.

Transferring from Sublocade® to Buvidal®.

PDF Transferring from Sublocade® to Buvidal®
Session date: December 1, 2021
Important: this session was in response to a temporary global shortage of the 300mg strength of Sublocade® from November 2021.

Transferring from methadone to long-acting injectable buprenorphine (LAIB).

PDF Transferring from methadone to long-acting injectable buprenorphine (LAIB).
Session date: December 8, 2021
Special considerations when transferring patients from methadone to LAIB

Buprenorphine for mental health.

PDF Buprenorphine for mental health.
Session date: September 15, 2021
Does buprenorphine have a role in treating some mental health disorders?

Overview of pharmacotherapies – methadone, buprenorphine incl. LAIB

PDF Overview of pharmacotherapies - methadone & buprenorphine including long-acting injectable buprenorphine.
Session date: February 3, 2021
Session 3 of our foundation series

Buprenorphine pharmacology

PDF Buprenorphine pharmacology
Session date: June 20, 2018

Buprenorphine-assisted withdrawal

PDF Buprenorphine-assisted withdrawal
Session date: June 1, 2019

The Bernese method for buprenorphine induction

PDF The Bernese method for buprenorphine induction
Session date:

Long-acting buprenorphine injection

PDF Long-acting buprenorphine injection
Session date:

Buprenorphine pharmacology

PDF Buprenorphine pharmacology
Session date:
An overview of buprenorphine's unique and complex pharmacology.

Search